Andon Health Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Yi Liu

Amministratore delegato

CN¥1.1m

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	17.4yrs
Proprietà del CEO	n/a
Durata media del management	6yrs
Durata media del Consiglio di amministrazione	4.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

Andon Health Co., Ltd.'s (SZSE:002432) Earnings Are Not Doing Enough For Some Investors

Nov 18

Andon Health (SZSE:002432) Is Doing The Right Things To Multiply Its Share Price

Oct 16

Andon Health's (SZSE:002432) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 08

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Mar 22

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

Mar 19

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Mar 01

AMMINISTRATORE DELEGATO

Yi Liu (57 yo)

17.4yrs

Mandato

CN¥1,069,600

Compensazione

Mr. Yi Liu is Chairman & GM of Andon Health Co., Ltd. from June 16, 2007.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Yi Liu	Chairman & GM	17.4yrs	CN¥1.07m	Nessun dato
Yong Wang	Director & Deputy GM	4.9yrs	CN¥1.04m	0.057% CN¥ 11.3m
Ming Cong	Deputy GM & Director	4.4yrs	CN¥801.70k	0.057% CN¥ 11.3m
Tong Wu	Board Secretary	7.1yrs	CN¥408.80k	0.019% CN¥ 3.8m

6.0yrs

Durata media

43.5yo

Età media

Gestione esperta: Il team dirigenziale di 002432 è esperto e expertise (durata media dell'incarico 6 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Yi Liu	Chairman & GM	17.4yrs	CN¥1.07m	Nessun dato
Yong Wang	Director & Deputy GM	4.9yrs	CN¥1.04m	0.057% CN¥ 11.3m
Ming Cong	Deputy GM & Director	4.4yrs	CN¥801.70k	0.057% CN¥ 11.3m
Shuguang He	Independent Director	less than a year	CN¥13.30k	Nessun dato
Kai Yao	Supervisory Board Chairman	16.9yrs	Nessun dato	Nessun dato
Zhiqing Liu	Supervisor	10.9yrs	Nessun dato	Nessun dato
Xinhui Zhai	Supervisor	4.9yrs	Nessun dato	Nessun dato
Xiaofang Bi	Independent Director	3.5yrs	CN¥80.00k	Nessun dato
Weijun Sun	Independent Director	4.3yrs	CN¥80.00k	Nessun dato

4.9yrs

Durata media

48yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 002432 sono considerati esperti (durata media dell'incarico 4.9 anni).

Andon Health Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Insufficient new directors

Andon Health Co., Ltd., Annual General Meeting, May 21, 2024

Andon Health Co., Ltd., Annual General Meeting, May 22, 2023

Andon Health Co., Ltd. Announces Executive Changes

No independent directors

Andon Health Co., Ltd., Annual General Meeting, May 20, 2022

Recent updates

Andon Health Co., Ltd.'s (SZSE:002432) Earnings Are Not Doing Enough For Some Investors

Third quarter 2024 earnings released: EPS: CN¥1.85 (vs CN¥0.24 in 3Q 2023)

Andon Health (SZSE:002432) Is Doing The Right Things To Multiply Its Share Price

Andon Health Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 18%

These 4 Measures Indicate That Andon Health (SZSE:002432) Is Using Debt Safely

Second quarter 2024 earnings released: EPS: CN¥0.83 (vs CN¥0.39 in 2Q 2023)

Andon Health Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Market Cool On Andon Health Co., Ltd.'s (SZSE:002432) Earnings

Insufficient new directors

Dividend of CN¥0.30 announced

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024

Is Andon Health (SZSE:002432) Using Too Much Debt?

Andon Health's (SZSE:002432) Weak Earnings May Only Reveal A Part Of The Whole Picture

Investor sentiment improves as stock rises 17%

Andon Health Co., Ltd., Annual General Meeting, May 21, 2024

Andon Health Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Investor sentiment improves as stock rises 15%

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Investor sentiment improves as stock rises 20%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Andon Health Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥1.77 in 3Q 2022)

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 1,000 million worth of its shares.

Second quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥2.04 in 2Q 2022)

Now 20% undervalued after recent price drop

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 13 June 2023

Andon Health Co., Ltd. Approves Dividend for 2022

Andon Health Co., Ltd., Annual General Meeting, May 22, 2023

First quarter 2023 earnings released: EPS: CN¥1.28 (vs CN¥31.39 in 1Q 2022)

Andon Health Co., Ltd. Announces Executive Changes

No independent directors

Third quarter 2022 earnings released: EPS: CN¥1.77 (vs CN¥0.01 loss in 3Q 2021)

Andon Health Co., Ltd. Approves Cash Dividend for the Year 2021

Andon Health Co., Ltd. Proposes Final Cash Dividend for the Year 2021

Andon Health Co., Ltd., Annual General Meeting, May 20, 2022

First quarter 2022 earnings released: EPS: CN¥31.39 (vs CN¥0.085 in 1Q 2021)

Insufficient new directors

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: CN¥2.01 (vs CN¥0.56 in FY 2020)

Third quarter 2021 earnings released: CN¥0.01 loss per share (vs CN¥0.24 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.037 (vs CN¥0.49 in 2Q 2020)

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 100 million worth of its shares.

Andon Health Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 03 June 2021

Andon Health Co., Ltd. Approves Cash Dividend for 2020

Third quarter 2020 earnings released: EPS CN¥0.24 (vs CN¥0.069 loss in 3Q 2019)

Andon Health Co., Ltd. Proposes Final Cash Dividend for 2020

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 100 million worth of its shares.

New 90-day low: CN¥8.43

New 90-day low: CN¥9.27

New 90-day low: CN¥9.33

New 90-day low: CN¥10.26

New 90-day low - CN¥10.30

First half earnings released

Andon Health Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media